Commonwealth Financial Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
AIM
AAMU
JWM
P
SAM
GIA
OIAM
Commonwealth Financial Services's DGX Position: Q2 2026 in Review
Commonwealth Financial Services reduced its Quest Diagnostics (DGX) stake by 20% in Q2 2026, selling an estimated $76.7K and leaving 1,589 shares worth $337K. The position accounts for 0.05% of the portfolio, ranked #195.
Commonwealth Financial Services first reported a position in DGX in Q3 2023 and has held it in 12 quarters since. The position peaked at $388K in Q1 2026. 182 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Commonwealth Financial Services held 1,589 shares of Quest Diagnostics worth $337K as of Q2 2026.
- Commonwealth Financial Services sold 391 Quest Diagnostics shares in Q2 2026, an estimated $76.7K.
- Quest Diagnostics made up 0.05% of Commonwealth Financial Services's portfolio in Q2 2026, its #195 holding.
- Commonwealth Financial Services first reported a position in Quest Diagnostics in Q3 2023 and has held it in 12 quarters since.
- Commonwealth Financial Services's Quest Diagnostics position peaked at $388K in Q1 2026.
- 182 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Commonwealth Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.